Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eculizumab in Japanese patients with hemolytic PNH (AEGIS)
NCT01192399Phase 2Completed
- Sponsor
- Alexion Pharmaceuticals
- Start
- Nov 2007
- Primary completion
- Jun 2008
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
01
Overview
A Phase 2 trial of eculizumab in paroxysmal nocturnal hemoglobinuria (PNH), sponsored by Alexion Pharmaceuticals. Started Nov 2007; status: completed.
02
Drugs
eculizumab
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on NCT01192399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01192399.